Paper77996
Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor.
Caspary WF. Lancet, 1978. Cited by 144 papers, by iCite.
Cite this record
ConductScience Library. Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor. Papers, record 77996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/77996
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enzyme Inhibitors | Major topic |
| Glucosidases | Major topic |
| Glycoside Hydrolase Inhibitors | Major topic |
| Malabsorption Syndromes | Major topic |
| Sucrose | Major topic |
| Administration, Oral | |
| Adult | |
| Blood Glucose | |
| Breath Tests | |
| Deuterium | |
| Female | |
| Glucosides | |
| Humans | |
| Hyperglycemia | |
| Intestinal Absorption | |
| Male | |
| Middle Aged |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40686634 | Inhibitory mechanism of pterostilbene and pinostilbene on aldose reductase and α-glucosidase: a new insight from inhibition kinetics and molecular docking studies. | RSC Adv | 2025 | https://conductscience.org/library/papers/40686634 | PubMed |
| 31061671 | Evaluation of In Vitro Antioxidant and Antidiabetic Activities of Aristolochia longa Extracts. | Evid Based Complement Alternat Med | 2019 | https://conductscience.org/library/papers/31061671 | PubMed |
| 29310631 | Acute effect of Clitoria ternatea flower beverage on glycemic response and antioxidant capacity in healthy subjects: a randomized crossover trial. | BMC Complement Altern Med | 2018 | https://conductscience.org/library/papers/29310631 | PubMed |
| 29204442 | In Vitro Screening of Three Indian Medicinal Plants for Their Phytochemicals, Anticholinesterase, Antiglucosidase, Antioxidant, and Neuroprotective Effects. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/29204442 | PubMed |
| 27547230 | Randomized, Double-Blinded, Double-Dummy, Active-Controlled, and Multiple-Dose Clinical Study Comparing the Efficacy and Safety of Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet and Acarbose in Individuals with Type 2 Diabetes Mellitus. | Evid Based Complement Alternat Med | 2016 | https://conductscience.org/library/papers/27547230 | PubMed |
| 24748931 | Phytotherapy in diabetes: Review on potential mechanistic perspectives. | World J Diabetes | 2014 | https://conductscience.org/library/papers/24748931 | PubMed |
| 16526817 | Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated? | Drugs | 2006 | https://conductscience.org/library/papers/16526817 | PubMed |
| 8972242 | Oral antidiabetic drug use in the elderly. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8972242 | PubMed |
| 8101498 | Effect of acarbose on glucose homeostasis, lipogenesis and lipogenic enzyme gene expression in adipose tissue of weaned rats. | Diabetologia | 1993 | https://conductscience.org/library/papers/8101498 | PubMed |
| 7028558 | Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months. | Diabetologia | 1981 | https://conductscience.org/library/papers/7028558 | PubMed |
| 6956411 | Dietary practices in obesity. | Bull N Y Acad Med | 1982 | https://conductscience.org/library/papers/6956411 | PubMed |
| 6350115 | Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery. | Gut | 1983 | https://conductscience.org/library/papers/6350115 | PubMed |
| 3956333 | New method of testing for carbohydrate absorption in man. Xylose and sucrose absorption; effects of sucrase inhibition. | Dig Dis Sci | 1986 | https://conductscience.org/library/papers/3956333 | PubMed |
| 3804023 | Regulation of the absorption of dietary carbohydrate in man by two new glycosidase inhibitors. | Gut | 1986 | https://conductscience.org/library/papers/3804023 | PubMed |
| 3542445 | Acute and short term effects of intestinal alpha-glucosidase inhibition on gut hormone responses in man. | Dig Dis Sci | 1987 | https://conductscience.org/library/papers/3542445 | PubMed |
| 3292164 | Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo. | Dig Dis Sci | 1988 | https://conductscience.org/library/papers/3292164 | PubMed |
| 3286212 | Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. | Drugs | 1988 | https://conductscience.org/library/papers/3286212 | PubMed |
| 3282895 | Effectiveness of acarbose, an alpha-glucosidase inhibitor, in uncontrolled non-obese non-insulin dependent diabetes. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3282895 | PubMed |
| 2988218 | Effect of Acarbose on the production of hydrogen and methane and on hormonal parameters in young adults under standardized low-fibre mixed diets. | Z Ernahrungswiss | 1985 | https://conductscience.org/library/papers/2988218 | PubMed |
| 2840365 | Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery. | Gut | 1988 | https://conductscience.org/library/papers/2840365 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/77996
GET https://conductscience.org/api/papers/v1/77996/cited_by?page=2